TY - JOUR
T1 - Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens
AU - Akatsuka, Yoshiki
AU - Nishida, Tetsuya
AU - Kondo, Eisei
AU - Miyazaki, Mikinori
AU - Taji, Hirohumi
AU - Iida, Hiroatsu
AU - Tsujimura, Kunio
AU - Yazaki, Makoto
AU - Naoe, Tomoki
AU - Morishima, Yasuo
AU - Kodera, Yoshihisa
AU - Kuzushima, Kiyotaka
AU - Takahashi, Toshitada
PY - 2003/6/2
Y1 - 2003/6/2
N2 - We report the identification of two novel minor histocompatibility antigens (mHAgs), encoded by two separate single nucleotide polymorphisms on a single gene, BCL2A1, and restricted by human histocompatibility leukocyte antigen (HLA)-A*2402 (the most common HLA-A allele in Japanese) and B*4403, respectively. Two cytotoxic T lymphocyte (CTL) clones specific for these mHAgs were first isolated from two distinct recipients after hematopoietic cell transplantation. Both clones lyse only normal and malignant cells within the hematopoietic lineage. To localize the gene encoding the mHAgs, two-point linkage analysis was performed on the CTL lytic patterns of restricting HLA-transfected B lymphoblastoid cell lines obtained from Centre d'Etude du Polymorphisme Humain. Both CTL clones showed a completely identical lytic pattern for 4 pedigrees and the gene was localized within a 3.6-cM interval of 15q24.3-25.1 region that encodes at least 46 genes. Of those, only BCL2A1 has been reported to be expressed in hematopoietic cells and possess three nonsynonymous nucleotide changes. Minigene transfection and epitope reconstitution assays with synthetic peptides identified both HLA-A*2402- and B*4403-restricted mHAg epitopes to be encoded by distinct polymorphisms within BCL2A1.
AB - We report the identification of two novel minor histocompatibility antigens (mHAgs), encoded by two separate single nucleotide polymorphisms on a single gene, BCL2A1, and restricted by human histocompatibility leukocyte antigen (HLA)-A*2402 (the most common HLA-A allele in Japanese) and B*4403, respectively. Two cytotoxic T lymphocyte (CTL) clones specific for these mHAgs were first isolated from two distinct recipients after hematopoietic cell transplantation. Both clones lyse only normal and malignant cells within the hematopoietic lineage. To localize the gene encoding the mHAgs, two-point linkage analysis was performed on the CTL lytic patterns of restricting HLA-transfected B lymphoblastoid cell lines obtained from Centre d'Etude du Polymorphisme Humain. Both CTL clones showed a completely identical lytic pattern for 4 pedigrees and the gene was localized within a 3.6-cM interval of 15q24.3-25.1 region that encodes at least 46 genes. Of those, only BCL2A1 has been reported to be expressed in hematopoietic cells and possess three nonsynonymous nucleotide changes. Minigene transfection and epitope reconstitution assays with synthetic peptides identified both HLA-A*2402- and B*4403-restricted mHAg epitopes to be encoded by distinct polymorphisms within BCL2A1.
UR - http://www.scopus.com/inward/record.url?scp=12444312572&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12444312572&partnerID=8YFLogxK
U2 - 10.1084/jem.20021925
DO - 10.1084/jem.20021925
M3 - Article
C2 - 12771180
AN - SCOPUS:12444312572
SN - 0022-1007
VL - 197
SP - 1489
EP - 1500
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 11
ER -